The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Astrazeneca Ab since year 2005.
The trader's CIK number is 928966.
At the time of the last reporting, Astrazeneca Ab was the 10% Owner of Entasis Therapeutics Holdings Inc. .
(stock ticker symbol ETTX).
See this page for all insider trading activities at Entasis Therapeutics Holdings Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-09-28||ETTX||Entasis Therapeutics Holdings Inc.||Buy||246,666||15.00||3,699,990|
|2017-12-01||ALBO||Albireo Pharma, Inc.||Sale||500,000||21.40||10,700,000|
|2014-11-12||RGLS||Regulus Therapeutics Inc.||Sale||2,000,000||17.00||34,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Astrazeneca Ab (10% Owner of Entasis Therapeutics Holdings Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.